tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

SelectQuote secures new $415 million credit facility

Story Highlights
  • SelectQuote closed a new $415 million credit facility in January 2026, refinancing prior debt and extending maturities to 2031.
  • The new Pathlight term loan and expanded UMB revolver improve liquidity, lower capital costs, and enhance operational flexibility for SelectQuote’s healthcare-focused platform.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
SelectQuote secures new $415 million credit facility

Claim 70% Off TipRanks Premium

SelectQuote ( (SLQT) ) has issued an announcement.

On January 8, 2026, SelectQuote entered into a new $415 million senior secured credit facility consisting of a $325 million term loan led by Pathlight Capital and a $90 million revolving credit facility with UMB Bank, using roughly $313.8 million of the term loan proceeds to fully repay its prior debt and cover transaction costs. Announced publicly on January 12, 2026, the financing significantly extends the company’s debt maturity to January 2031, modestly lowers its cost of capital, increases peak-season revolver capacity from $72 million to $90 million, and reduces principal amortization requirements, collectively strengthening liquidity and operational flexibility as the company looks to leverage its roughly $1 billion in commissions receivable and the growing cash generation of its SelectRx and healthcare services operations, while its obligations remain secured by substantially all company and guarantor subsidiary assets and subject to customary covenants, coverage ratios, and borrowing-base tests tied to receivables.

The most recent analyst rating on (SLQT) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.

Spark’s Take on SLQT Stock

According to Spark, TipRanks’ AI Analyst, SLQT is a Neutral.

SelectQuote’s overall score reflects a mix of positive revenue growth and operational improvements, offset by significant profitability and cash flow challenges. The technical indicators suggest bearish momentum, and the valuation is unattractive due to negative earnings. The earnings call provided some optimism with growth in certain segments, but unmet fiscal targets and EBITDA losses weigh heavily on the outlook.

To see Spark’s full report on SLQT stock, click here.

More about SelectQuote

SelectQuote, Inc., founded in 1985 and listed on the NYSE under ticker SLQT, is a leading distributor of Medicare insurance policies and operates a rapidly growing healthcare services platform, including its SelectRx pharmacy business and virtual care offerings. The company pioneered a model that provides consumers with unbiased comparisons among multiple highly rated insurance carriers, supported by a large team of trained agents and proprietary lead-generation technology, and now runs an integrated ecosystem spanning insurance, pharmacy, and healthcare services for senior and other consumers.

Average Trading Volume: 1,010,100

Technical Sentiment Signal: Sell

Current Market Cap: $248.1M

See more data about SLQT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1